You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stem cell transplantation

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

Not yet recruiting
  • Relapsed Acute Myeloid Leukaemia
  • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
  • (no location specified)
Jul 4, 2023

Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

Enrolling by invitation
  • Hepatitis B Reactivation
  • +3 more
  • Seoul, Korea, Republic of
    Jeong Won Jang
Dec 16, 2022

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Stem Cell Transplantation Trial in Cairo (conjunctival limbal autologous transplant)

Recruiting
  • Stem Cell Transplantation
  • conjunctival limbal autologous transplant
  • Cairo, Egypt
    Kasr Alainy
Aug 9, 2022

B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

Recruiting
  • B-cell Lymphoma
  • ASCT+CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

COVID-19, Hematopoietic Stem Cell Transplantation Trial in Tianjin (COVID Convalescent Plasma)

Recruiting
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
  • COVID Convalescent Plasma
  • Tianjin, None Selected, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 13, 2023

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

CIBMTR Research Database

Recruiting
  • Autologous Stem Cell Transplantation
  • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 20, 2023

    Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)

    Not yet recruiting
    • Spinal Cord Injuries
    • Mesenchymal stem cell transplantation
    • Placebo
    • Salvador, Bahia, Brazil
      Senai Cimatec
    Jan 10, 2023

    Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

    Active, not recruiting
    • Leukemia
    • +3 more
    • Palifermin
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Haemoglobin Barts Hydrops Trial in Sha Tin (in-utero HSCT)

    Recruiting
    • Haemoglobin Barts Hydrops
    • in-utero HSCT
    • Sha Tin, Hong Kong
      The Chinese University of Hong Kong
    Mar 21, 2023

    Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

    Recruiting
    • Acute Leukemia
    • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
    • haploidentical hematopoietic stem cell transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Aug 9, 2022

    Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

    Active, not recruiting
    • Lymphoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 10, 2023

    Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

    Not yet recruiting
    • Cytomegaloviral Infection
    • Hematopoietic and Lymphoid System Neoplasm
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 16, 2022

    Hematological Malignancy Trial (Thymoglobulin Injectable Product)

    Not yet recruiting
    • Hematological Malignancy
    • Thymoglobulin Injectable Product
    • (no location specified)
    Sep 27, 2023

    People Undergoing Hematopoietic Stem Cell Transplantation

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Tissue Donors
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 24, 2022

      Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

      Not yet recruiting
      • Multiple Myeloma
      • Stem Cell Transplant Complications
      • PARE
      • Waitlist Control Group
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 30, 2023

      AML/MDS Trial in Copenhagen (iDLI)

      Recruiting
      • AML/MDS
      • iDLI
      • Copenhagen, Denmark
        Copenhagen University Hospital, Rigshospitalet
      Jan 13, 2023

      GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)

      Not yet recruiting
      • GATA2
      • Immunodeficiency
      • Mycophenolate Mofetil
      • +7 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 23, 2023

      Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

      Recruiting
      • COVID-19
      • Hematopoietic Stem Cell Transplantation
        • Suzhou, Jiangsu, China
          First Affiliated Hospital of Soochow University
        Jan 10, 2023

        Immune Reconstitution After Allo-HSCT and Blinatumomab

        Not yet recruiting
        • Leukemia, Lymphoid
        • (no location specified)
        Oct 3, 2023

        Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

        Recruiting
        • Well-being of Caregivers (Caregiver Strain Index)
        • home care
        • Durham, North Carolina
          Duke University Medical Center
        Jan 25, 2023

        Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

        Completed
        • Multiple Myeloma
        • allogeneic HSCT
        • Hamburg, Germany
          University Medical Center Hamburg-Eppendorf
        Sep 1, 2022